Lisa Colleran was appointed CEO of Vivex Biomedical Inc. Tracy Anderson, former president, CEO and founder of Vivex, transitioned from CEO to take on the role of vice chairman. Colleran was the former CEO of LifeCell Corporation. Vivex is a regenerative biomedical company.
David Sunseri, Ph.D., was appointed CEO of PMI BioPharma Solutions.
Eloiza Domingo-Snyder has been appointed to executive director of diversity and inclusion at Astellas US.
Wei Lin, M.D., became senior VP of clinical development and head of oncology programs at Nektar Therapeutics.
Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, appointed Todd Zavodnick as CEO.
Gabriel Vargas, M.D., Ph.D., is now chief medical officer of CuraSen Therapeutics Inc.
Allergan plc announced that Daphne Karydas took on the new role of senior VP, corporate financial planning and analysis and strategy, and Manisha Narasimhan, Ph.D., joined the company as VP of investor relations and strategic initiatives, effective December 10, 2018.
Scott Partridge, former VP of global strategy for Monsanto – now part of Bayer – was named the company’s U.S. General Counsel.
Arena Pharmaceuticals Inc. appointed Robert Lisicki as executive VP and chief commercial officer, and Paul K. Audhya, M.D., MBA, as senior VP, Medical Affairs. Lisicki reports to Amit D. […]
Less than 8 percent of respondents to a research study of clinical trial participants felt that the potential negative consequences of data sharing outweighed the benefits.
